Described herein are pharmaceutical packaging programs which protect against oxidative degradation of morphine, hydromorphone, promethazine along with other oxygen-sensitive drugs, these types of methods such as a syringe having an oxygen permeable idea cap, a hermetically sealed oxygen barrier blister packaging with really reduced permeability to